Anthocyanidins, novel FAK inhibitors, attenuate PDGF-BB-induced aortic smooth muscle cell migration and neointima formation

Cardiovascular Research

Volumn 101, Issue 3, 2014, Pages 503-512

  Son, Joe Eun ^a   Lee, Eunjung ^a   Jung, Sung Keun ^a,b   Kim, Jong Eun ^a,c   Oak, Min Ho ^e   Lee, Ki Won ^a,c,d   Lee, Hyong Joo ^a,c  

^a Seoul National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

^e Mokpo National University   (South Korea)

Author keywords

Anthocyanindins; Aortic smooth muscle cell; Atherosclerosis; Focal adhesion kinase; Migration

Indexed keywords

ANTHOCYANINDINS; AORTIC SMOOTH MUSCLE CELL; ATHEROSCLEROSIS; FOCAL ADHESION KINASE; MIGRATION;

ANIMALS; ANTHOCYANINS; AORTA; CELL MOVEMENT; CELLS, CULTURED; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-SIS; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; WOUND HEALING;

EID: 84894598416     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt337     Document Type: Article

References (44)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
2. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscl Thromb Vasc Biol 2008;28:812-819.
3. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004;15: 237-254.
4. Ronnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int J Cancer 2001;91:757-762.
5. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, NakatsujiNet al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-544.
6. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005;6:56-68.
7. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000;2: 249-256.
8. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954-963.
9. Ilic D, Kovacic B, McDonagh S, Jin F, Baumbusch C, Gardner DG et al. Focal adhesion kinase is required for blood vessel morphogenesis. Circ Res 2003;92:300-307.
10. Cheng Z, Sundberg-Smith LJ, Mangiante LE, Sayers RL, Hakim ZS, Musunuri S et al. Focal adhesion kinase regulates smooth muscle cell recruitment to the developing vasculature. Arterioscler Thromb Vasc Biol 2011;31:2193-2202.
11. Koshman YE, Chu M, Engman SJ, Kim T, Iyengar R, Robia SL et al. Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhesion targeting, tyrosine 168 phosphorylation, and competition for p130(Cas) binding. Arterioscler Thromb Vasc Biol 2011;31:2432-2440.
12. Taylor JM, Mack CP, Nolan K, Regan CP, Owens GK, Parsons JT. Selective expression of an endogenous inhibitor of FAKregulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol 2001;21:1565-1572.
13. Mazza G. Anthocyanins in grapes and grape products. Crit Rev Food Sci Nutr 1995;35: 341-371.
14. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 2008;87:323-331.
15. Renaud S, Gueguen R. The French paradox and wine drinking. Novartis Found Symp 1998; 216:208-217; discussion 217-222, 152-208.
16. Hou DX, Kai K, Li JJ, Lin S, Terahara N, Wakamatsu M et al. Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms. Carcinogenesis 2004;25:29-36.
17. Kim JE, Kwon JY, Seo SK, Son JE, Jung SK, Min SY et al. Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1. Biochem Pharmacol 2010;79:1473-1482.
18. Kwon JY, Lee KW, Kim JE, Jung SK, Kang NJ, Hwang MK et al. Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcinogenesis 2009;30:1932-1940.
19. Hwang MK, Kang NJ, Heo YS, LeeKW, Lee HJ. Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. Biochem Pharmacol 2009;77:1213-1222.
20. Oak MH, Bedoui JE, Madeira SV, Chalupsky K, Schini-Kerth VB. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br J Pharmacol 2006;149:283-290.
21. XuJW, Ikeda K, YamoriY. Inhibitory effect of polyphenol cyanidinon TNF-alpha-induced apoptosis through multiple signaling pathways in endothelial cells. Atherosclerosis 2007; 193:299-308.
22. Choi KH, Kim JE, Song NR, Son JE, Hwang MK, Byun S et al. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells. Cardiovasc Res 2010;85:836-844.
23. Lee HM, Jeon BH, Won KJ, Lee CK, Park TK, Choi WS et al. Gene transfer of redox factor-1 inhibits neointimal formation: involvement of platelet-derived growth factorbeta receptor signaling via the inhibition of the reactive oxygen species-mediated Syk pathway. Circ Res 2009;104:219-227, 215p following 227.
24. Tulis DA. Rat carotid artery balloon injury model. Methods Mol Med 2007;139:1-30.
25. GoncuT, Tiryakioglu O, Ozcan A, Ari H, Sezen M, VuralHet al. Inhibitory effects of ticlopidine and clopidogrel on the intimal hyperplastic response after arterial injury. Anadolu Kardiyol Derg 2010;10:11-16.
26. Byun S, LeeKW, Jung SK, Lee EJ, Hwang MK, Lim SH et al. Luteolin inhibits protein kinase C(epsilon) and c-Src activities and UVB-induced skin cancer. Cancer Res 2010;70: 2415-2423.
27. Skalli O, Pelte MF, Peclet MC, Gabbiani G, Gugliotta P, Bussolati G et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 1989;37:315-321.
28. Slack-Davis JK, Martin KH, TilghmanRW, Iwanicki M, Ung EJ, AutryCet al. Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 2007;282: 14845-14852.
29. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109:III27-III32.
30. Shen TL, Park AY, Alcaraz A, Peng X, Jang I, Koni P et al. Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis. J Cell Biol 2005;169:941-952.
31. CarragherNO, Frame MC. Focal adhesion and actin dynamics: a place where kinases and proteases meet to promote invasion. Trends Cell Biol 2004;14:241-249.
32. HertogMG, Hollman PC, KatanMB, KromhoutD. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 1993;20:21-29.
33. Hassimotto NM, Genovese MI, Lajolo FM. Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr Res 2008;28:198-207.
34. Xia X, LingW, Ma J, Xia M, Hou M, WangQet al.An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. J Nutr 2006;136:2220-2225.
35. Mauray A, Felgines C, Morand C, Mazur A, Scalbert A, Milenkovic D. Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice. Genes Nutr 2010;5:343-353.
36. Wang Y, Zhang Y, Wang X, Liu Y, Xia M. Supplementation with cyanidin-3-O-beta-glucoside protects against hypercholesterolemia-mediated endothelial dysfunction and attenuates atherosclerosis in apolipoprotein E-deficient mice. J Nutr 2012;142:1033-1037.
37. LeeKW, Bode AM, Dong Z. Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer 2011;11:211-218.
38. Kang NJ, LeeKW, Kwon JY, HwangMK, Rogozin EA, Heo YS et al. Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogenactivated protein kinase kinase/extracellular signal-regulated kinase signaling. Cancer Prev Res (Phila) 2008;1:522-531.
39. Lamy S, Beaulieu E, Labbe D, Bedard V, Moghrabi A, Barrette S et al. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008;29:1033-1041.
40. Schlaepfer DD, Mitra SK. Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 2004;14:92-101.
41. Sayers RL, Sundberg-Smith LJ, Rojas M, Hayasaka H, Parsons JT, Mack CP et al. FRNK expression promotes smooth muscle cell maturation during vascular development and after vascular injury. Arterioscler Thrombosis Vasc Biol 2008;28:2115-2122.
42. Tavora B, Batista S, Reynolds LE, Jadeja S, Robinson S, Kostourou V et al. Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med 2010;2:516-528.
43. Braren R, HuH, Kim YH, Beggs HE, Reichardt LF, Wang R. Endothelial FAKis essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 2006;172: 151-162.
44. Kang NJ, Shin SH, Lee HJ, LeeKW. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis. Pharmacol Ther 2011;130:310-324.